Investment Rating - The report maintains an investment rating of "Outperform the Market - A" for the biopharmaceutical sector [8]. Core Insights - Recent advancements in the overseas expansion of domestic innovative drugs have been noted, including overseas sales, NDA approvals, and product licensing [2]. - The report highlights significant sales figures for BeiGene's BTK inhibitor, Zebrutinib, with global sales reaching $1.816 billion in the first three quarters of 2024, and $690 million in Q3 2024 alone [2][30]. - The report emphasizes the increasing market share of Zebrutinib, which reached 21.8% globally and 24.9% in the U.S. market in Q3 2024 [30]. Summary by Sections Weekly New Drug Market Review - From November 11 to November 15, 2024, the top five companies in the new drug sector by stock price increase were: - CStone Pharmaceuticals (15.98%) - Ascletis Pharma (5.04%) - Zai Lab (4.51%) - LianBio (4.11%) - Eternity Bioscience (3.89%) - The top five companies with the largest declines were: - Kintor Pharmaceutical (-19.31%) - Eucure Biopharma (-16.06%) - Junshi Biosciences (-14.63%) - Sihuan Pharmaceutical (-14.52%) - ZhiXiang JinTai (-14.39%) [1][25]. Key Analysis of the New Drug Industry - Recent progress in the overseas expansion of domestic innovative drugs includes: 1. NDA submissions: Dicerna Pharmaceuticals submitted an NDA for the drug Suvoritide to the FDA, and Betta Pharmaceuticals is expected to receive final review results for its ALK-positive NSCLC NDA by December 28, 2024 [2][30]. 2. Overseas sales: BeiGene reported global sales of Zebrutinib reaching $1.816 billion in the first three quarters of 2024, with Q3 sales of $690 million, including $504 million in the U.S. (up 87% year-on-year) and $97 million in Europe (up 217% year-on-year) [2][30]. 3. Overseas licensing: Recent collaborations include BioNTech's acquisition of Promis and Merck's licensing agreement for the PD-1/VEGF bispecific antibody LM-299 from LianBio, with an upfront payment of $588 million [2][37]. New Drug Approvals and Applications - This week, four new drugs or new indications were approved for market entry, with 46 new drugs receiving IND approvals, 38 IND applications accepted, and 7 NDA applications accepted [38]. - Notable approvals include: - Merck's global exclusive license for LianBio's PD-1/VEGF bispecific antibody [38]. - BioNTech's acquisition of Promis for $800 million [38].

Investment Rating - The report maintains an investment rating of "Outperform" compared to the market [5]. Core Insights - The report highlights the rapid development of AI terminal applications, particularly with the launch of Baidu's AI glasses expected in 2025, which features advanced functionalities and low power consumption [1]. - The semiconductor industry is entering a new era with the introduction of 300mm silicon carbide substrates by Tianyue Advanced, catering to the growing demand from clean energy and high-power applications [2]. - The global smartphone market has shown continuous growth for four consecutive quarters, with a 2% year-on-year increase in shipments in Q3 2024, reaching 307 million units [3]. Summary by Sections 1. Industry News Overview - Baidu's AI glasses are set to launch in 2025, featuring a lightweight design and multiple smart functionalities [1]. - Tianyue Advanced's 300mm silicon carbide substrate marks a significant advancement in the domestic silicon carbide industry [2]. - The global smartphone market has seen a 10% increase in revenue in Q3 2024, reaching a record high for the quarter [3]. 2. Industry Data Tracking 2.1 Semiconductor - Global semiconductor sales reached $166 billion in Q3 2024, reflecting a 23.2% year-on-year growth [44]. 2.2 SiC - The introduction of 300mm silicon carbide substrates is expected to enhance chip production efficiency and reduce costs [48]. 2.3 Consumer Electronics - In Q3 2024, global smartphone shipments totaled 307 million units, marking a 2% increase year-on-year [54]. 3. Market Review - The electronic sector saw a 9.36% increase in the week of November 4-8, 2024, with semiconductors leading the gains at 11.98% [59][62]. - The electronic index's price-to-earnings (PE) ratio stands at 56.78, indicating a high valuation compared to historical averages [67].

| --- | --- | --- | --- | |-------|-------|--------------------------|----------------------------| | | | | | | | | | | | | | 国投证券研究报告 2024W46 | 2024年11 月16日 国投家电 | 双11期间扫地机增长亮眼 家电行业首席分析师李奕臻： 今年双11国家以旧换新补贴叠加电商平台优惠， 消费者购买家电能享受更大的折扣力度。以爆款 新品扫地机为例，其补贴后的折扣可达7折左右。 2024W42~W45 扫地机、台式烤箱、空调、电视的 线上销售额增长良好；其中扫地机的同比增速超 过50%，表现突出。 行业评级：领先大市-A 风险提示：行业竞争风险、原材料价格波动风险 等。 以旧换新刺激需求，双11扫地机、烤箱、空调、电视线上增长良好 ◼ 在以旧换新补贴和平台补贴的刺激下，2024年双11期间（2024W42~W45）扫地机、台式烤箱、空调、电视 的线上零售额增长良好。同时，以旧换新带动了家电结构升级和均价提升，空调、冰箱、电视、扫地机等 品类的线上零售额增速高于零售量增速。 ...

Industry Investment Rating - The report maintains a "Leading the Market - A" rating for the industry [6] Core Views - The robotics industry faces short-term profit pressure, with weak downstream demand and a slow recovery in the manufacturing sector [1] - The humanoid robot sector is expected to accelerate industrialization, with mass production anticipated by 2025 [8] - Industrial robots are experiencing weak demand recovery, while domestic substitution is accelerating [2] Market Performance - The robotics sector showed thematic investment characteristics, with significant volatility driven by humanoid robot events [1] - From the beginning of 2024 to November 8, 2024, the robotics sector rose by 17.69%, underperforming the CSI 300 index [1] - The sector experienced multiple phases of volatility, influenced by macroeconomic factors, Tesla's announcements, and policy support [17] Financial Performance - In Q1-Q3 2024, the sample companies' total revenue was 39.172 billion yuan, a year-on-year decrease of 1.18%, while net profit attributable to the parent company was 2.29 billion yuan, down 24.78% year-on-year [1] - The gross profit margin of the sector was 26.01%, up 0.28 percentage points year-on-year, while the net profit margin was 5.85%, down 1.83 percentage points [1] - Operating cash flow improved significantly, with a net operating cash flow of 2.575 billion yuan, a year-on-year increase of 102.7% [1] Industrial Robots - In Q1-Q3 2024, China's industrial robot sales reached 216,000 units, a year-on-year increase of 5%, while production was 416,300 units, up 11.5% year-on-year [2] - The domestic substitution rate of industrial robots increased from 24.2% in 2017 to 45.1% in 2023, and further to 50.1% in H1 2024 [2] - The industrial robot density in China reached 392 units per 10,000 people in 2022, higher than the global average of 151 units per 10,000 people [53] Humanoid Robots - The Ministry of Industry and Information Technology (MIIT) released the "Guiding Opinions on the Innovative Development of Humanoid Robots," targeting mass production by 2025 [8] - AI advancements are expected to significantly boost the robotics industry, with humanoid robots likely to achieve industrial breakthroughs [64] - Domestic companies such as Ubtech, Fourier, and Unitree are actively developing and iterating humanoid robot products [68][69] Key Companies - Companies like Estun, Efort, and Tuosda are highlighted in the industrial robot sector, with varying performance in revenue and profit [25] - In the humanoid robot sector, companies such as Ubtech, Fourier, and Unitree are making significant progress in product development and commercialization [69] Investment Recommendations - Focus on industrial robot companies with strong product capabilities and customer resources, such as Estun, Efort, and Tuosda [9] - Pay attention to the progress of humanoid robot industrialization and key component suppliers, including companies like Mingzhi Electric, Beite Technology, and Green Harmony [9]

2024 年 11 月 15 日 传媒 行业分析 证券研究报告 出版专题：红利防守，横向逻辑或可加 持 投资评级 领先大市-A 维持评级 首选股票 目标价（元） 评级 行业具备高准入壁垒，地方出版集团竞争地位稳固。在出版产 业链中，一般模式是以出版牵头，带动印刷、发行和出版物资贸 易三个环节的发展，体现为出版毛利率>发行毛利率>印刷毛利率> 物资销售毛利率，出版、发行为产业链最关键的两个环节。图书 出版与发行行业有较高的准入壁垒，多个地方政府将旗下出版集 团和发行集团打包成为区域性国有出版集团来进行上市融资。地 方性出版集团具备牌照优势和股权优势，大多形成集出版、印刷、 出版物资贸易、发行为一体产业链，在区域内享有稳固地位。 教材教辅经营稳健，一般图书企稳回升。国资背景出版公司主 要收入来源多为教辅教材的出版、发行，受益于教材教辅业务高 壁垒、稳定特性，其经营稳健，体现在报表层面，2021-2023 年收 入同比增速基本维持在-10%至+10%以内；利润端也整体呈现稳中 有增，2023 年受税收政策变化引起的一次性收益进一步放大增长 趋势。在一般图书方面，2023 年，疫后复苏带来图书零售市场恢 复和发展的新 ...

Investment Rating - The investment rating for the company is "Buy-A" with a 12-month target price of 11.2 CNY, compared to the current stock price of 9.21 CNY [4]. Core Insights - The company plans to acquire 100% equity of Shandong Heavy Industry Group's subsidiary, Shandong Construction Machinery, for 1.841 billion CNY, which will enhance its excavator business segment [1][2]. - The acquisition is expected to create synergies between the company's existing product lines and Shandong Construction Machinery's excavators, improving overall competitiveness [2][6]. - Shandong Construction Machinery has shown strong financial performance, with revenues of 2.426 billion CNY and net profits of 0.75 billion CNY for the first three quarters of 2024, exceeding the entire revenue and profit of 2023 [3][7]. Financial Projections - Revenue projections for the company from 2024 to 2026 are 13.44 billion CNY, 15.81 billion CNY, and 18.2 billion CNY, with growth rates of 27.5%, 17.7%, and 15.1% respectively [7][8]. - Net profit estimates for the same period are 0.95 billion CNY, 1.21 billion CNY, and 1.43 billion CNY, with growth rates of 24.6%, 26.5%, and 18.7% respectively [7][8]. - The company is expected to maintain a price-to-earnings (PE) ratio of 14.5X, 11.5X, and 9.7X for the years 2024, 2025, and 2026 respectively [7][8]. Market Position and Strategy - Shandong Construction Machinery holds a market share of 4.03% in the excavator segment, with a competitive position in the industry [2]. - The acquisition is part of a broader strategy to resolve competition issues within the Shandong Heavy Industry Group and to potentially pursue further asset restructuring in the future [6][7]. - The company aims to leverage its leading position in the engineering machinery sector to enhance its value chain through this acquisition [2][6].

Investment Rating - The semiconductor equipment sector is rated as "Outperform" with a target price for key stocks such as Northern Huachuang at 408.58 CNY and Zhongwei Company at 175.24 CNY, both rated as "Buy-A" [5]. Core Insights - The semiconductor equipment sector exhibits "high prosperity + strong catalyst" characteristics, with significant revenue growth for core companies in Q3 2024, driven by the recovery of terminal demand and advancements in technology [1][22]. - The sector has seen a 45.11% increase year-to-date, outperforming the CSI 300 index, which rose by 19.61% [2][22]. - The focus on "self-control" in the context of the US-China technology competition is expected to accelerate the development of domestic semiconductor equipment [1][3]. Market and Operational Overview - The semiconductor equipment sector's performance is highlighted by a significant revenue increase for major companies such as Northern Huachuang (80.2 million CNY, +30.1% YoY) and Zhongwei Company (20.6 million CNY, +36% YoY) in Q3 2024 [24][26]. - The net profit margins for platform companies like Northern Huachuang and Zhongwei Company have improved, with net profit margins of 20.3% and 16%, respectively [25][27]. - The import of advanced lithography machines from the Netherlands remains high, with 68 units valued at 30.3 billion USD expected in Q4 2024, supporting domestic production capacity [3][34]. Future Outlook - The semiconductor equipment market is projected to grow by 4% in 2024, reaching approximately 105.3 billion USD, driven by recovery in terminal demand [34][35]. - The focus on advanced manufacturing processes and the need for improved yield rates in domestic production are key themes for future capital expenditures [1][3]. - The ongoing competition in the semiconductor equipment sector is expected to intensify as companies shift towards a platform-based model, increasing R&D investments [28][29].

Investment Rating - The report maintains an "Outperform" rating for the shipbuilding sector, with specific stock recommendations including "Buy" for China Shipbuilding (600150) and "Hold" for China Power (600482) [4]. Core Insights - The shipbuilding sector is experiencing a recovery in profitability, driven by rising prices and efficiency improvements, alongside ongoing mergers and acquisitions [6]. - The report highlights a significant increase in new ship orders, with a 61% year-on-year growth in global new ship orders from January to September 2024, indicating strong demand [3][24]. - The shipping market has faced downward pressure on freight rates since July 2024, impacting stock performance in the sector [28]. Summary by Sections 1. Shipbuilding Sector Q3 2024 Summary - Stock performance in Q3 2024 showed mixed results, with China Shipbuilding and China Power gaining 3.14% and 24.36% respectively, while China Heavy Industry and China Ship Defense saw declines [2][11]. - As of Q3 2024, the order backlog for major companies includes China Shipbuilding with 199.6 billion CNY in civil ship orders, indicating robust future revenue potential [1]. 2. Industry Tracking and Outlook - New ship prices have increased by 6.0% since the beginning of 2024, with slight growth in bulk carriers and container ships [3][20]. - The global new ship order volume reached 12,866 million deadweight tons in the first nine months of 2024, with container ship orders increasing by 98% year-on-year [3][24]. - The shipping market has seen a decline in freight rates, with the Shanghai Container Freight Index dropping 44.77% from July to October 2024 [28][29]. 3. Investment Recommendations - The report suggests focusing on the shipbuilding cycle driven by "Juga Cycle + New Energy" trends, recommending leading companies like China Shipbuilding and China Power for their potential to benefit from rising prices and cost advantages [6]. - The ongoing merger between China Shipbuilding and China Heavy Industry is expected to enhance competitive dynamics and profitability in the sector [6].

达到 1.78万亿,突破 2022年的高位,创下 2015年以来的新高。 2024 年 11 月 13 日 庶民的胜利:交易热度接近峰值 目报告摘要: 尽管市场涨势较好,尤其是小微盘和低价股涨幅明显,但以公募基金为代表的 机构资金事实上在 10月9日之后的行情中参与度不高,首先观察偏股型基金指 数相对 wind 全 A 的相对指数走势,可以发现在一般情况下,偏股型基金的相对 收益和绝对收益有一个较强的相关性,这是因为长期以来机构黄金以及审美奏 似的北向资金拥有 A 股市场的主要定价权。但今年以来偏股型基金的相对收益 和绝对收益出现明显背离,9月底反弹以来,偏股型基金整体取得了一定绝对收 益，但是并没有获得超额收益，这说明当前市场定价权已经从主动型公墓机构 相关报告 和外资转移到了散户游资等高风险偏好资金以及 ETF 为代表的被动多头资金, 这一结论也可以从我们近期对于增量资金的分析中得到印证。 huangwz1@essence.com.cn 除融资贵金以外，还有两个观察散户活跃度的指标——全 A 换手率和每月新开 户数,在机构整体参与度较低+外资流出的背景下,全A成交额 10月至今一直 维持在2万亿到2.5万 ...

Investment Rating - The report maintains an "Outperform" rating for the engineering machinery sector, indicating a positive outlook compared to the broader market [6]. Core Insights - The engineering machinery industry is experiencing a bottoming recovery, with profit elasticity accelerating due to improved operational efficiency and cost control measures [1][7]. - The sector's performance has been stronger than the market, with a year-to-date increase of 24.89% compared to the 22.47% rise in the CSI 300 index [1][14]. - The report highlights that the revenue for the engineering machinery sector reached 248.95 billion yuan in the first three quarters of 2024, reflecting a year-on-year growth of 1.8%, driven primarily by international sales [1][18]. Summary by Sections 1. Engineering Machinery: Revenue Steady with Accelerated Profit Release - The engineering machinery sector's revenue and profit both achieved positive growth during the bottoming phase, with total revenue of 2489.49 billion yuan and net profit of 213.87 billion yuan, marking increases of 1.8% and 14.31% year-on-year, respectively [18][24]. - The sector's gross margin and net margin improved to 25.66% and 8.89%, respectively, due to lower raw material costs and enhanced operational efficiency [24]. 2. Market Outlook: Narrow Fluctuations Expected, Structural Alpha Remains Key - The report anticipates that the industry will continue to experience narrow fluctuations, with structural alpha being the main focus, particularly in emerging markets [2][10]. - Domestic demand is expected to recover gradually, supported by infrastructure investments and fiscal policies, while export growth is projected to stabilize [2][10]. 3. Investment Recommendations - The report suggests focusing on leading companies with strong recovery potential, such as SANY Heavy Industry, XCMG, and Zoomlion, which are expected to benefit from demand recovery and improved competitiveness in international markets [7][19]. - Companies with significant exposure to excavators and high market shares in emerging markets are highlighted as potential investment opportunities [2][7].